Bedel Financial Consulting’s Rockwell Medical RMTI Stock Holding History

Bedel Financial Consulting’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1	Closed	–	–	781
2019 Q3	$0	Hold	1	–	–	﹤0.01%	767
2019 Q2	$0	Buy	+1	New	+$508	﹤0.01%	743

Other funds holding RMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bedel Financial Consulting's RMTI Position: Q4 2019 in Review

Bedel Financial Consulting sold out of Rockwell Medical (RMTI) in Q4 2019, closing a stake of 1 share.

Bedel Financial Consulting first reported a position in RMTI in Q2 2019 and held it in 2 quarters. The position peaked at $0 in Q3 2019. 83 funds tracked by Wall St. Rank hold RMTI as of Q4 2019.

Bedel Financial Consulting reported no remaining Rockwell Medical position as of Q4 2019 after selling out during the quarter.
Bedel Financial Consulting sold 1 Rockwell Medical share in Q4 2019.
Bedel Financial Consulting first reported a position in Rockwell Medical in Q2 2019 and held it in 2 quarters.
Bedel Financial Consulting's Rockwell Medical position peaked at $0 in Q3 2019.
83 funds tracked by Wall St. Rank held Rockwell Medical as of Q4 2019.

Based on Bedel Financial Consulting's 13F filing for Q4 2019, filed 28 Jan 2020.